Source Natural Foods and Herbal Supplements Limited (531398) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Source Natural Foods and Herbal Supplements Limited ₹159, price ₹107, upside +47.7%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Source Natural Foods and Herbal Supplements Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range ₹80.91 – ₹264.50 · fair‑value band ₹106.50 – ₹181.79 · the ₹107.40 price screens below the ₹158.60 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Source Natural Foods and Herbal Supplements in your weekly email
Every Wednesday you see whether Source Natural Foods and Herbal Supplements is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Source Natural Foods and Herbal Supplements Limited manufactures and sells Ayurvedic medicines and herbal supplements products in India. The company was formerly known as Inwinex Pharmaceuticals Limited and changed its name to Source Natural Foods and Herbal Supplements Limited in June 2012.
Show more
Source Natural Foods and Herbal Supplements Limited manufactures and sells Ayurvedic medicines and herbal supplements products in India. The company was formerly known as Inwinex Pharmaceuticals Limited and changed its name to Source Natural Foods and Herbal Supplements Limited in June 2012. Source Natural Foods and Herbal Supplements Limited was incorporated in 1995 and is based in Bengaluru, India. Source Natural Foods and Herbal Supplements Limited is a subsidiary of Sumeru Ayurveda Private Limited.
Stock analysis
Source Natural Foods and Herbal Supplements Limited (531398) currently trades at ₹107.40, while our model-based Fair Value estimate is ₹158.60, implying the stock looks roughly 32.3% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹335.81 per share, and 13 of the 15 models we run sit above the ₹107.40 price.
Bear case: the Asset-Based group reads lowest at ₹42.41, and 2 of the 15 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹106.50 (bear) to ₹181.79 (bull), the price of ₹107.40 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Other sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Source Natural Foods and Herbal Supplements Limited reported revenue of ₹704M in FY2026 versus ₹215M in FY2022, a compound +34.5%/yr. Reported net income was ₹34.0M in FY2026, compounding +8.7%/yr from FY2022.
Key figures
Market cap ₹691M (≈ $7.2M) · P/E ratio 26.6 · P/S ratio 1.28 · EPS (TTM) ₹2.55 · Net margin 4.8% · Return on assets (EBIT) 13.9% · Free cash flow −₹30.9M · Net debt ₹55.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Other peers we cover trades at −10% fair-value upside, at 48%, 531398 screens cheaper than that median.
Fair Value models
Bear ₹106.50Fair Value ₹158.60Bull ₹181.79
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹1.30 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+56.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+52.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.1%
Start year 2021 (pandemic). Over 10 years: +20.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+0.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.2%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.6.9% vs 9.2%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 8%
2026 sits 60% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Compare Source Natural Foods and Herbal Supplements Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Other · 141 stocks
Beats the industry median on 6/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score54 · Above median
Fair Value upside+63.4% · Top 25%
Profitability
Return on assets0.0% · Above median
Net margin (TTM)4.8% · Above median
Operating margin (TTM)0.0% · Above median
Growth and dividend
Revenue growth0.0% · Top 25%
Dividend yield (TTM)0.0% · Bottom 25%
Valuation Multiplesvs Other median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Source Natural Foods and Herbal Supplements Limited Fair Value". https://www.fairvalue-calculator.com/stock/531398
Frequently asked questions
Is Source Natural Foods and Herbal Supplements Limited (531398) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of ₹158.60 versus a price of ₹107.40, about +48% upside (undervalued).
What is the fair value of 531398?
Our model-based fair value for Source Natural Foods and Herbal Supplements Limited is ₹158.60 (as of Oct 3, 2026), built from audited fundamentals. The current price: ₹107.40.
What is the quality score of 531398?
Source Natural Foods and Herbal Supplements Limited has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Source Natural Foods and Herbal Supplements Limited (531398)?
Our model-based price target is the fair value of ₹158.60 (as of Oct 3, 2026) from 15 valuation models. Cautious scenario ₹106.50, optimistic scenario ₹181.79. It is a calculation from audited fundamentals, not an analyst target.
What is the Source Natural Foods and Herbal Supplements Limited stock forecast for 2026?
Our models put fair value at ₹158.60, about +48% upside versus a price of ₹107.40 (undervalued). Cautious scenario ₹106.50, optimistic scenario ₹181.79. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Source Natural Foods and Herbal Supplements Limited (531398)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Source Natural Foods and Herbal Supplements Limited it is ₹158.60 per share (as of Oct 3, 2026), against a price of ₹107.40. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is Source Natural Foods and Herbal Supplements Limited stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 531398 trades below its calculated fair value: price ₹107.40, fair value ₹158.60, a gap of about +48% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 531398?
No. The price is what the market pays today (₹107.40); the fair value is what the company's own numbers justify (₹158.60). For Source Natural Foods and Herbal Supplements Limited the two are ₹51.20 per share apart. That gap is exactly why we show both numbers side by side.
How much is Source Natural Foods and Herbal Supplements Limited worth?
The market values Source Natural Foods and Herbal Supplements Limited at about ₹691M (market capitalisation, as of Oct 3, 2026). Per share that is ₹107.40; our models calculate a fair value of ₹158.60 per share.
What do the bullish and bearish scenarios say about 531398?
Our models span a range for Source Natural Foods and Herbal Supplements Limited: cautious scenario ₹106.50, base ₹158.60, optimistic ₹181.79 per share (as of Oct 3, 2026, price ₹107.40). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 531398?
Source Natural Foods and Herbal Supplements Limited trades at a price-to-earnings ratio of 26.6 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹158.60 is built from several models across several years.
How far is 531398 from its 52-week high?
Source Natural Foods and Herbal Supplements Limited trades at ₹107.40, about 31% below its 52-week high of ₹154.70 and 5% above the low of ₹102.40 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹158.60 is for.
Which stocks are comparable to Source Natural Foods and Herbal Supplements Limited?
From the same area (Other) we also value 542772, 590024, Indiabulls Real Estate Limited, 542851, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Source Natural Foods and Herbal Supplements Limited stock attractive at the current price?
The data as of Oct 3, 2026: price ₹107.40, calculated fair value ₹158.60 (+48%), Quality Score 54/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 531398 calculated?
We run Source Natural Foods and Herbal Supplements Limited through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹158.60, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Source Natural Foods and Herbal Supplements Limited currently trades 32 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Source Natural Foods and Herbal Supplements Limited (531398)?
The closing price on Oct 1, 2026 was ₹107.40. Our model-based fair value is ₹158.60, about +48% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Source Natural Foods and Herbal Supplements Limited right now?
The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Source Natural Foods and Herbal Supplements Limited
How large is the market capitalisation of Source Natural Foods and Herbal Supplements Limited (531398)?
The market capitalisation of Source Natural Foods and Herbal Supplements Limited is ₹691M (≈ $7.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Source Natural Foods and Herbal Supplements Limited (531398)?
The price-to-sales ratio of Source Natural Foods and Herbal Supplements Limited is 1.28 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Source Natural Foods and Herbal Supplements Limited (531398)?
Earnings per share at Source Natural Foods and Herbal Supplements Limited are ₹2.55 (price ÷ EPS = P/E 26.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Source Natural Foods and Herbal Supplements Limited (531398)?
The net margin of Source Natural Foods and Herbal Supplements Limited is 4.8% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Source Natural Foods and Herbal Supplements Limited (531398)?
On an EBIT basis the return on assets of Source Natural Foods and Herbal Supplements Limited is 13.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Source Natural Foods and Herbal Supplements Limited (531398) generate?
The free cash flow of Source Natural Foods and Herbal Supplements Limited is −₹30.9M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Source Natural Foods and Herbal Supplements Limited (531398) carry?
The net debt of Source Natural Foods and Herbal Supplements Limited is ₹55.8M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Source Natural Foods and Herbal Supplements Limited in the live analysis
One click puts Source Natural Foods and Herbal Supplements Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
